The Effect of Turmeric Decoctum to the Angiogenic Molecules Expression on Chicken Embryo

Sultanah Zahariah, Sri Winarsih, Siti Candra Windu Baktiyani, Bambang Rahardjo, Umi Kalsum

Abstract


Turmeric (Curcuma longa) is widely used as herbal medicine, not an exception by pregnant women. Turmeric consumption by expectant mothers requires standard dose, because of its antiangiogenic effect could be harmful on placentation process and embryonic development. This experiment was undertaken to determine the effect of different concentrations of turmeric decoctum to the expression of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) and Angiopoietin 1 (Ang-1) on the 48-hours-old chicken embryo. In this study, turmeric was extracted using decoction method to mimic the common method as adopted by people. The turmeric decoctum were freeze dried into a powder form and was used in preparing the stock solution for 200 ppm (P1), 300 ppm (P2), and 400 ppm (P3) as experimental treatments. The control group (P0) received 2% DMSO without turmeric decoctum. These were administered on the yolk sack of 16 hours incubation of fertile chicken egg by number of 200 µL. After 48 hours incubation, the expression of VEGFR-2 and Ang-1 on the chicken embryo were counted by ImageJ software. The results revealed that there is no significant effect of turmeric decoctum to the expression of VEGFR-2 and Ang-1. This suggested that turmeric decoctum was safe up to 400 ppm on chicken embryo.


Keywords


Turmeric, angiogenic molecues, VEGFR-2, Ang-1

Full Text:

PDF

References


Akram M, Uddin S, Ahmed A et al. (2010) Curcuma longa and curcumin: A review article. Romanian Journal of Biology - Plant Biology 55 (2): 65-70.

Paryono AK (2014) Kebiasaan Konsumsi Jamu untuk Menjaga Kesehatan Tubuh pada Saat Hamil dan Setelah Melahirkan di Desa Kajoran Klaten Selatan. Jurnal Terpadu Ilmu Kesehatan 3 (1): 64-72.

Purnamawati D, Ariawan I (2012) Konsumsi Jamu Ibu Hamil sebagai Faktor Risiko Asfiksia Bayi Baru Lahir. Jurnal Kesehatan Masyarakat Nasional 6 (6): 267-272.

Handayani L (2003) Membedah rahasia ramuan Madura. Jakarta, Agromedia Pustaka.

Bhandarkar SS, Arbiser JL (2007) Curcumin as an inhibitor of angiogenesis. In: Mol. Targets Ther. Uses Curcumin Heal. Boston, Springer.

Wang Y, Zhao S (2010) Vascular biology of the placenta. Morgan and Claypool Life Science, California.

Zygmunt M, Herr F, Münstedt K et al. (2003) Angiogenesis and Vasculogenesis in Pregnancy. European Journal of Obstetrics and Gynecology and Reproductive Biology 110: S10–S18.

Olsson AK, Dimberg A, Kreuger J, Lena CW (2006) VEGF receptor signalling — in control of vascular function. Nature Reviews-Molecular Cell Biology 7 (5): 359-371.

Patel-Hett S, D’Amore PA (2011) Signal transduction in vasculogenesis and developmental angiogenesis. The International Journal of Developmental Biology 55 (4–5): 353-363.

Carlson BM (2014) Human embryology and developmental biology 5th edition. Sanders Elsevier, Philadelphia.

Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes and Cancer 2 (12): 1097–1105.

Syrjala S (2014) Critical role of angiopoietin pathway in ischemia reperfusion injury in cardiac transplantation. [dissertation]. Helsinki: University of Helsinki.

Drake VJ, Koprowski SL, Lough JW, Smith SM (2006) Gastrulating chick embryo as a model for evaluating teratogenicity: A comparison of three approaches. Birth Defects Research (PartA): Clinical and Molecular Teratology 76: 66–71.

Hamburger V, Hamilton HL (1951) A series of normal stages of development of the chick embryo. J Morph 88: 4962.

Drake VJ, Koprowski SL, Lough JW, Smith SM (2006) Gastrulating chick embryo as a model for evaluating teratogenicity: A comparison of three approaches. Birth Defects Research (PartA): Clinical and Molecular Teratology. 76: 66–71.

Mason I, Sharpe PT (1999) Molecular embryology methods and protocols second edition, Sharpe, P and Mason, I editors. Heidelberg, Humana Press part of Springer Science and Business Media, LLC doi: 10.1007/978-1-60327-483-8.

Rahayu ID, Djati MS, Indra MR (2011) Hambatan EGCG terhadap ekspresi VEGF dan VE-Chaderin Embrio Ayam. The Journal of Experimental Life Science 1 (2): 56-110.

Liu D, Schwimer J, Liu Z et al. (2008) Antiangiogenic Effect of Curcumin in Pure Versus in Extract Forms. Pharmaceutical Biology 46 (10–11): 677–682.

El-Azab M, Hishe H, Moustafa Y, El-Awady S (2011) Antiangiogenic effect of resveratrol or curcumin in ehrlich ascites carcinoma bearing mice. European Journal of Pharmacology 652: 7–14.

Bae MK, Kim SH, Jeong JW et al. (2006) Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncology Reports 15 (6): 1557-1562.

Choi H, Chun YS, Kim SW et al. (2006) Curcumin inhibits hypoxia-induced factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth Inhibition. Molecular Pharmacology 70 (5): 1664-1671.

Hasima, Aggarwal B (2014) Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment. Current Medicinal Chemistry 21 (14): 1583-1594.

Marcu MG, Jung YJ, Lee S et al. (2006) Curcumin is an inhibitor of P300 histone acetylatransferase. Medicinal Chemistry 2 (2): 74-169. doi: 10.2174/157340606776056133.

Krock BL, Skuli N, Simon MC (2011) Hypoxia-induced angiogenesis: good and evil. Genes and Cancer 2 (12): 1117–1133.

Mattson MP (2008) Hormesis defined. HIH Public Access Author Manuscript 7 (1): 1–7.

Gururaj AE, Belakavadi M, Venkates DA et al. (2002) Molecular mechanisms of anti-angiogenic effect of curcumin. Biochemical and Biophysical Research Communications 297 (4): 934–942. doi: 10.1016/S0006-291X(02)02306-9.




DOI: http://dx.doi.org/10.11594/jtls.07.02.10

Copyright (c) 2017 Journal of Tropical Life Science